Evidence map›Paper›PMID 36297394›Full record

ReviewPharmaceuticals (Basel, Switzerland)2022

4D Printing of Hydrogels: Innovation in Material Design and Emerging Smart Systems for Drug Delivery.

Tuan Sang Tran, Rajkamal Balu, Srinivas Mettu, Namita Roy Choudhury, Naba Kumar Dutta

Abstract readReview
In one paragraph

Review in Pharmaceuticals (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed.

  1. Biomimetic Scaffold-Based 3D Models for Decoding Cancer Biology and Advancing Therapy.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
    Review
  2. Review
  3. Review
  4. Review
  5. Review
  6. Article
  7. Review
  8. Dynamic Hydrogels in Breast Tumor Models.Gels (Basel, Switzerland) · 2025
    Review
  9. Review
  10. Review
  11. Review
  12. Review
  13. Hydrogel-Based Continuum Soft Robots.Gels (Basel, Switzerland) · 2025
    Review
  14. Extrusion bioprinting: meeting the promise of human tissue biofabrication?Progress in biomedical engineering (Bristol, England) · 2025
    Review
  15. Review
  16. Review
  17. Review
  18. Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Tuan Sang TranSchool of Engineering, RMIT University, Melbourne, VIC 3000, Australia.ORCID 0000-0002-0047-9571
Rajkamal BaluSchool of Engineering, RMIT University, Melbourne, VIC 3000, Australia.ORCID 0000-0002-2748-8734
Srinivas MettuSchool of Engineering, RMIT University, Melbourne, VIC 3000, Australia.ORCID 0000-0002-8645-8818
Namita Roy ChoudhurySchool of Engineering, RMIT University, Melbourne, VIC 3000, Australia.ORCID 0000-0001-9010-8506
Naba Kumar DuttaSchool of Engineering, RMIT University, Melbourne, VIC 3000, Australia.ORCID 0000-0003-4800-1910

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Advancements in the material design of smart hydrogels have transformed the way therapeutic agents are encapsulated and released in biological environments. On the other hand, the expeditious development of 3D printing technologies has revolutionized the fabrication of hydrogel systems for biomedical applications. By combining these two aspects, 4D printing (i.e., 3D printing of smart hydrogels) has emerged as a new promising platform for the development of novel controlled drug delivery systems that can adapt and mimic natural physio-mechanical changes over time. This allows printed objects to transform from static to dynamic in response to various physiological and chemical interactions, meeting the needs of the healthcare industry. In this review, we provide an overview of innovation in material design for smart hydrogel systems, current technical approaches toward 4D printing, and emerging 4D printed novel structures for drug delivery applications. Finally, we discuss the existing challenges in 4D printing hydrogels for drug delivery and their prospects.

Indexed as

3D printing4D printingdrug deliverysmart hydrogelsstimuli-responsive polymers

Identifiers

PMID36297394
PMCPMC9609121

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.